These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 12756892)

  • 21. Neuroendocrine cells of the prostate and neuroendocrine differentiation in prostatic carcinoma: a review of morphologic aspects.
    di Sant'Agnese PA
    Urology; 1998 May; 51(5A Suppl):121-4. PubMed ID: 9610566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model.
    Bonkhoff H; Remberger K
    Prostate; 1996 Feb; 28(2):98-106. PubMed ID: 8604398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroendocrine differentiation in prostatic malignancy.
    di Sant'Agnese PA; Cockett AT
    Cancer; 1996 Jul; 78(2):357-61. PubMed ID: 8674017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The spectrum of neuroendocrine tumors: histologic classification, unique features and areas of overlap.
    Klimstra DS; Beltran H; Lilenbaum R; Bergsland E
    Am Soc Clin Oncol Educ Book; 2015; ():92-103. PubMed ID: 25993147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endocrine-paracrine cell types in the prostate and prostatic adenocarcinoma are postmitotic cells.
    Bonkhoff H; Stein U; Remberger K
    Hum Pathol; 1995 Feb; 26(2):167-70. PubMed ID: 7532147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential.
    Masumori N; Thomas TZ; Chaurand P; Case T; Paul M; Kasper S; Caprioli RM; Tsukamoto T; Shappell SB; Matusik RJ
    Cancer Res; 2001 Mar; 61(5):2239-49. PubMed ID: 11280793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Endocrine disrupting chemicals and carcinogenesis--breast, testis and prostate cancer].
    Imaida K; Shirai T
    Nihon Rinsho; 2000 Dec; 58(12):2527-32. PubMed ID: 11187749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumour suppressor gene products, proliferation, and differentiation markers in lung neuroendocrine neoplasms.
    Barbareschi M; Girlando S; Mauri FA; Arrigoni G; Laurino L; Dalla Palma P; Doglioni C
    J Pathol; 1992 Apr; 166(4):343-50. PubMed ID: 1355531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Ectopic ACTH- or CRH-secreting tumors in Cushing's syndrome].
    Saeger W; Reincke M; Scholz GH; Lüdecke DK
    Zentralbl Pathol; 1993 Jun; 139(2):157-63. PubMed ID: 8396419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Endocrine tumors: biology and physiopathology].
    Scoazec JY
    Ann Pathol; 2005 Dec; 25(6):447-61. PubMed ID: 16735972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Divergent differentiation in neoplasms. Pathologic, biologic, and clinical considerations.
    Mendelsohn G; Maksem JA
    Pathol Annu; 1986; 21 Pt 1():91-119. PubMed ID: 3510419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Site-specific epithelial-mesenchymal interactions in digestive neuroendocrine tumors. An experimental in vivo and in vitro study.
    Dumortier J; Ratineau C; Scoazec JY; Pourreyron C; Anderson W; Jacquier MF; Blanc M; Bernard C; Bellaton C; Remy L; Chayvialle JA; Roche C
    Am J Pathol; 2000 Feb; 156(2):671-83. PubMed ID: 10666396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroendocrine cells in benign prostatic hyperplasia and prostatic carcinoma: effect of hormonal treatment.
    Guate JL; Escaf S; Menendez CL; del Valle M; Vega JA
    Urol Int; 1997; 59(3):149-53. PubMed ID: 9428430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evolving Concepts and Translational Relevance of Enteroendocrine Cell Biology.
    Drucker DJ
    J Clin Endocrinol Metab; 2016 Mar; 101(3):778-86. PubMed ID: 26649620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Precursor lesions of endocrine system neoplasms.
    Mete O; Asa SL
    Pathology; 2013 Apr; 45(3):316-30. PubMed ID: 23478233
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A TNM classification for digestive endocrine tumors of midgut and hindgut: proposals from the European Neuroendocrine Tumor Society (ENETS)].
    Couvelard A; Scoazec JY
    Ann Pathol; 2007 Dec; 27(6):426-32. PubMed ID: 18554552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oncocytic lesions of the neuroendocrine system.
    Baloch ZW; LiVolsi VA
    Semin Diagn Pathol; 1999 May; 16(2):190-9. PubMed ID: 10452583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 4.7 Biological modeling as a method for data evaluation and integration in toxicology.
    Barton HA
    Hum Exp Toxicol; 2009 Feb; 28(2-3):143-5. PubMed ID: 19713382
    [No Abstract]   [Full Text] [Related]  

  • 39. More similar than you think: Frog metamorphosis as a model of human perinatal endocrinology.
    Buchholz DR
    Dev Biol; 2015 Dec; 408(2):188-95. PubMed ID: 25744725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Galanin immunoreactivity in neuroendocrine tumors.
    Sano T; Vrontakis ME; Kovacs K; Asa SL; Friesen HG
    Arch Pathol Lab Med; 1991 Sep; 115(9):926-9. PubMed ID: 1718239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.